News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hong Kong CK Life Sciences International Plans A$10M Biotech R&D Spending In Australia



10/19/2005 5:11:55 PM

Hong Kong-based CK Life Sciences International (Holdings) Ltd. (8222.HK) plans to spend A$10 million on biotechnology research and development in Victoria, Australia, the Australian government said Tuesday. "Our government will work closely with them to provide support, facilitation and assistance to the project, as well as help identify opportunities for R&D collaboration in Victoria," said Victorian State Premier Steve Bracks.

Read at Dow Jones


comments powered by Disqus
Dow Jones
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES